Form 8-K - Current report:
SEC Accession No. 0001140361-24-041344
Filing Date
2024-09-18
Accepted
2024-09-18 07:40:47
Documents
23
Period of Report
2024-09-18
Items
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K ef20036017_8k.htm   iXBRL 8-K 36215
2 EXHIBIT 99.1 ef20036017_ex99-1.htm EX-99.1 37608
3 EXHIBIT 99.2 ef20036017_ex99-2.htm EX-99.2 19724
7 ef20036017_ex99-2slide1.jpg GRAPHIC 136317
8 ef20036017_ex99-2slide2.jpg GRAPHIC 254361
9 ef20036017_ex99-2slide3.jpg GRAPHIC 122591
10 ef20036017_ex99-2slide4.jpg GRAPHIC 146160
11 ef20036017_ex99-2slide5.jpg GRAPHIC 142893
12 ef20036017_ex99-2slide6.jpg GRAPHIC 183172
13 ef20036017_ex99-2slide7.jpg GRAPHIC 98951
14 ef20036017_ex99-2slide8.jpg GRAPHIC 98546
  Complete submission text file 0001140361-24-041344.txt   1880968

Data Files

Seq Description Document Type Size
4 XBRL TAXONOMY EXTENSION SCHEMA roiv-20240918.xsd EX-101.SCH 3862
5 XBRL TAXONOMY EXTENSION LABEL LINKBASE roiv-20240918_lab.xml EX-101.LAB 21966
6 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE roiv-20240918_pre.xml EX-101.PRE 16042
25 EXTRACTED XBRL INSTANCE DOCUMENT ef20036017_8k_htm.xml XML 4218
Mailing Address CLARENDON HOUSE 2 CHURCH STREET HAMILTON D0 HM11
Business Address CLARENDON HOUSE, 2 CHURCH STREET HAMILTON HM11 D0 HM11 441-295-5950
Roivant Sciences Ltd. (Filer) CIK: 0001635088 (see all company filings)

EIN.: 981173944 | State of Incorp.: D0 | Fiscal Year End: 0331
Type: 8-K | Act: 34 | File No.: 001-40782 | Film No.: 241306186
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)